Evidence map›Paper›PMID 34588209›Full record

ArticleDiabetes care2021

Association of Type 2 Diabetes, According to the Number of Risk Factors Within Target Range, With Structural Brain Abnormalities, Cognitive Performance, and Risk of Dementia.

April C E van Gennip, Coen D A Stehouwer, Martin P J van Boxtel, Frans R J Verhey, Annemarie Koster, Abraham A Kroon, Sebastian Köhler, Marleen M J van Greevenbroek, Anke Wesselius, Simone J P M Eussen and 6 more

Abstract read
In one paragraph

Article in Diabetes care, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

April C E van GennipDepartment of Internal Medicine, Maastricht University Medical Centre, Maastricht, the Netherlands.
Coen D A StehouwerDepartment of Internal Medicine, Maastricht University Medical Centre, Maastricht, the Netherlands.
Martin P J van BoxtelSchool for Mental Health and Neuroscience MHENS, Maastricht University, Maastricht, the Netherlands.
Frans R J VerheySchool for Mental Health and Neuroscience MHENS, Maastricht University, Maastricht, the Netherlands.
Annemarie KosterCare and Public Health Research Institute CAPHRI, Maastricht University, Maastricht, the Netherlands.
Abraham A KroonDepartment of Internal Medicine, Maastricht University Medical Centre, Maastricht, the Netherlands.
Sebastian KöhlerSchool for Mental Health and Neuroscience MHENS, Maastricht University, Maastricht, the Netherlands.
Marleen M J van GreevenbroekDepartment of Internal Medicine, Maastricht University Medical Centre, Maastricht, the Netherlands.
Anke WesseliusSchool of Nutrition and Translational Research in Metabolism NUTRIM, Maastricht University, Maastricht, the Netherlands.
Simone J P M EussenSchool for Cardiovascular Diseases CARIM, Maastricht University, Maastricht, the Netherlands.
Walter H BackesSchool for Mental Health and Neuroscience MHENS, Maastricht University, Maastricht, the Netherlands.
Jacobus F JansenSchool for Mental Health and Neuroscience MHENS, Maastricht University, Maastricht, the Netherlands.
Miranda T SchramDepartment of Internal Medicine, Maastricht University Medical Centre, Maastricht, the Netherlands.
Ronald M A HenryDepartment of Internal Medicine, Maastricht University Medical Centre, Maastricht, the Netherlands.
Archana Singh-ManouxEpidemiology of Ageing and Neurodegenerative Diseases, Université de Paris, INSERM U1153, Paris, France.
Thomas T van SlotenDepartment of Internal Medicine, Maastricht University Medical Centre, Maastricht, the Netherlands t.vansloten@maastrichtuniversity.nl.ORCID 0000-0003-2870-482X

Funding

Role of mid- and late-life risk factors in social inequalities in Alzheimer's Disease and Related DementiasRF1AG062553 · NIA · INSERM PARIS 5 · PI KIVIMAKI, MIKA J, SINGH-MANOUX, ARCHANA · 2019 to 2019
$1.5M
Education and Aging: transitions from multi-morbidity to functional limitationsR56AG056477 · NIA · UNIVERSITY COLLEGE LONDON · PI KIVIMAKI, MIKA J, SINGH-MANOUX, ARCHANA · 2017 to 2017
$365k
Medical Research Council MC_PC_17228Medical Research Council MC_QA137853NIA NIH HHS R56 AG056477NIA NIH HHS RF1 AG062553
6 · The paper itself

Abstract

objectiveType 2 diabetes is associated with increased risks of cognitive dysfunction and brain abnormalities. The extent to which risk factor modification can mitigate these risks is unclear. We investigated the associations between incident dementia, cognitive performance, and brain abnormalities among individuals with type 2 diabetes, according to the number of risk factors on target, compared with control subjects without diabetes. RESEARCH DESIGN AND

methodsProspective data were from UK Biobank of 87,856 individuals (

resultsAfter a mean follow-up of 9.0 years, 147 individuals (1.4%) with diabetes and 412 control subjects (0.5%) had incident dementia. Among individuals with diabetes, excess dementia risk decreased stepwise for a higher number of risk factors on target. Compared with control subjects (incidence rate per 1,000 person-years 0.62 [95% CI 0.56; 0.68]), individuals with diabetes who had five to seven risk factors on target had no significant excess dementia risk (absolute rate difference per 1,000 person-years 0.20 [-0.11; 0.52]; hazard ratio 1.32 [0.89; 1.95]). Similarly, differences in processing speed, executive function, and brain volumes were progressively smaller for a higher number of risk factors on target. These results were replicated in the Maastricht Study.

conclusionsAmong individuals with diabetes, excess dementia risk, lower cognitive performance, and brain abnormalities decreased stepwise for a higher number of risk factors on target.

Indexed as

Cognitive DysfunctionDementiaDiabetes Mellitus, Type 2BrainCognitionHumansMagnetic Resonance ImagingProspective StudiesRisk Factors

Identifiers

PMID34588209
PMCPMC9612883

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.